Telmisartan ameliorates cisplatin-induced nephrotoxicity by inhibiting MAPK mediated inflammation and apoptosis
Authors:
- 1 February 2015
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 748, 54-60
Abstract
No abstract availableKeywords
Funding Information
- All India Institute of Medical Sciences, New Delhi
This publication has 30 references indexed in Scilit:
- Protective effect of telmisartan against cadmium-induced nephrotoxicity in miceLife Sciences, 2011
- Nephroprotective Effect of Telmisartan in Rats with Ischemia/Reperfusion Renal InjuryPharmacology, 2010
- The protective role of telmisartan against nephrotoxicity induced by X-ray contrast media in rat modelActa Radiologica, 2009
- Effect of JNK inhibition on cisplatin-induced renal damageNephrology Dialysis Transplantation, 2007
- Long-Term Renoprotective Effects of Standard Versus High Doses of Telmisartan in Hypertensive Nondiabetic NephropathiesAmerican Journal of Kidney Diseases, 2005
- Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study*Acta Diabetologica, 2005
- Cisplatin nephrotoxicitySeminars in Nephrology, 2003
- Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injuryKidney International, 2001
- [13] Catalase in vitro1984
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976